CAS: 125093-93-8 - (lys1,pro2,5,arg3,4,tyr6)-vasoactive*intestinal P
Fórmula:C154H257N49O40S
- Sinónimos:
- VIP Antagonist
- H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | VIP Antagonist REF: 01-4031352CAS: 125093-93-8 | 95.3% | 272,00 €~474,00 € | Lun 25 Nov 24 |
 | VIP Antagonist REF: 3D-PVA-3757-PICAS: 125093-93-8 | Min. 95% | 559,00 €~2.003,00 € | Mar 10 Dic 24 |
| VIP Antagonist REF: 3D-PP50098CAS: 125093-93-8 | - - - | A consultar | Mar 10 Dic 24 |
| VIP Antagonist REF: 3D-FV110467CAS: 125093-93-8 | Min. 95% | 343,00 €~3.053,00 € | Vie 24 Ene 25 |
VIP Antagonist
CAS:125093-93-8
VIP antagonist, a hybrid of neurotensin (6-11) and VIP (7-28), is a competitive antagonist of …
Fórmula:
C154H257N49O40S
Pureza:
95.3%
Forma y color:
White
Peso molecular:
3467.11
Ref: 01-4031352
| 1mg | 474,00 € | ||
| 0.5mg | 272,00 € |
Entrega estimada en Estados Unidos, el Lunes 25 de Noviembre de 2024
VIP Antagonist
CAS:125093-93-8
VIP Antagonist is a drug that inhibits the α7 nicotinic acetylcholine receptor and has been …
Fórmula:
C154H257N49O40S
Pureza:
Min. 95%
Peso molecular:
3,764.13 g/mol
Ref: 3D-PVA-3757-PI
| 1mg | 559,00 € | ||
| 5mg | 2.003,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
VIP Antagonist
CAS:125093-93-8
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool
Fórmula:
C154H257N49O40S
Peso molecular:
3,467.13 g/mol
Ref: 3D-PP50098
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
VIP Antagonist
CAS:125093-93-8
The VIP antagonist is a model system that has been shown to inhibit the activity …
Fórmula:
C154H257N49O40S
Pureza:
Min. 95%
Peso molecular:
3,467.06 g/mol
Ref: 3D-FV110467
| 1mg | 877,00 € | ||
| 2mg | 1.414,00 € | ||
| 5mg | 3.053,00 € | ||
| 250µg | 343,00 € | ||
| 500µg | 532,00 € |
Entrega estimada en Estados Unidos, el Viernes 24 de Enero de 2025
